版本:
中国

BRIEF-Actelion says granted marketing authorization by European Commission for Ledaga

March 7 Actelion Ltd

* Actelion is granted marketing authorization by the European Commission for Ledaga (chlormethine gel) for the treatment of MF-CTCL Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

更多 瑞士市场报道

热门文章

编辑推荐

文章推荐